Privia Health Group, Inc. $PRVA Shares Sold by OMERS ADMINISTRATION Corp

OMERS ADMINISTRATION Corp reduced its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 18.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 368,695 shares of the company’s stock after selling 83,896 shares during the quarter. OMERS ADMINISTRATION Corp’s holdings in Privia Health Group were worth $7,584,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Renaissance Group LLC purchased a new stake in Privia Health Group in the 4th quarter valued at about $7,776,000. Principal Financial Group Inc. increased its position in shares of Privia Health Group by 1.6% in the fourth quarter. Principal Financial Group Inc. now owns 2,787,802 shares of the company’s stock worth $66,099,000 after acquiring an additional 43,589 shares in the last quarter. Louisiana State Employees Retirement System acquired a new stake in shares of Privia Health Group in the first quarter worth $1,055,000. Van Berkom & Associates Inc. raised its stake in shares of Privia Health Group by 5.4% in the 1st quarter. Van Berkom & Associates Inc. now owns 4,053,043 shares of the company’s stock valued at $83,371,000 after acquiring an additional 208,787 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in shares of Privia Health Group by 26.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 148,709 shares of the company’s stock valued at $3,703,000 after acquiring an additional 30,845 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on PRVA. Barclays lowered their price target on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a report on Tuesday, May 26th. Citigroup reaffirmed a “buy” rating on shares of Privia Health Group in a research report on Thursday. Weiss Ratings upgraded Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, July 2nd. Evercore set a $26.00 price target on Privia Health Group in a research report on Wednesday, April 8th. Finally, Zacks Research cut Privia Health Group from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 7th. Eleven equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $31.15.

Privia Health Group Stock Performance

Shares of PRVA stock opened at $25.50 on Monday. The company’s 50-day simple moving average is $24.40 and its 200-day simple moving average is $23.33. Privia Health Group, Inc. has a one year low of $18.77 and a one year high of $28.82. The stock has a market capitalization of $3.21 billion, a price-to-earnings ratio of 159.38, a PEG ratio of 2.02 and a beta of 0.83.

Insider Activity at Privia Health Group

In other news, CEO Parth Mehrotra sold 15,647 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $22.64, for a total transaction of $354,248.08. Following the completion of the transaction, the chief executive officer directly owned 434,357 shares in the company, valued at approximately $9,833,842.48. The trade was a 3.48% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO David Mountcastle sold 21,275 shares of Privia Health Group stock in a transaction on Thursday, July 9th. The shares were sold at an average price of $27.67, for a total value of $588,679.25. Following the sale, the chief financial officer directly owned 164,853 shares in the company, valued at $4,561,482.51. The trade was a 11.43% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 478,855 shares of company stock worth $12,099,109 in the last ninety days. 5.70% of the stock is owned by insiders.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.